President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, are quickly slapped down in ...

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Flagship Harbor Advisors LLC cut its position in iShares 0-5 Year TIPS Bond ETF (NYSEARCA:STIP – Free Report) by 7.8% during ...

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

Janney Montgomery Scott LLC lifted its position in Airbnb, Inc. (NASDAQ:ABNB – Free Report) by 25.5% during the 4th quarter, ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...

We recently compiled a list of the 12 Safest Stocks to Buy According to Hedge Funds. In this article, we are going to take a ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...